You are here

Home

Vaccines

Primary tabs

Thu, 2015-01-08 20:48 — mdmcdonald
Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Kathy Gilbeaux mdmcdonald MDMcDonald_me_com mike kraft
Subscribe to group

Email address for group

vaccines_global@m.resiliencesystem.org

FDA head says agency could consider authorization for Covid-19 vaccine before Phase 3 trials are complete, Financial Times reports

Mon, 2020-08-31 11:59 — mike kraft
FDA leader says agency could consider authorization for Covid-19 vaccine before Phase 3 trials are complete, Financial Times reports FDA Commissioner, Dr. Stephen Hahn, told the Financial Times that the organization would consider emergency use authorization for a Covid-19 vaccine before Phase 3 trials were completed Jamie Gumbrecht, CNN CNN
Country / Region Tags: 
Europe
Global
UK - London
United Kingdom
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Government
Health
Pandemics
Policy
Politics
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report

EU offers 400 million euros to WHO-led COVID-19 vaccine initiative

Mon, 2020-08-31 11:33 — mike kraft
EU offers 400 million euros to WHO-led COVID-19 vaccine initiative The European Commission said it would contribute 400 million euros ($478 million) to an initiative led by the World Health Organization to buy COVID-19 vaccines, but did not clarify whether EU states would acquire shots through the WHO scheme. Francesco Guarascio U.S.
Country / Region Tags: 
Europe
United Kingdom
General Topic Tags: 
COVID-19
Disease
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Large U.S. covid-19 vaccine trials are halfway enrolled, but lag on participant diversity

Fri, 2020-08-28 12:58 — mike kraft
Large U.S. covid-19 vaccine trials are halfway enrolled, but lag on participant diversity Moderna and Pfizer are halfway to signing up the 30,000 participants they need for the final stage of testing. But only about a fifth are Black or Hispanic. Carolyn Y. Johnson Washington Post
Country / Region Tags: 
United States
US - NorthWest
General Topic Tags: 
COVID-19
Data
Demographics
Disease
Health
Pandemics
Population
Research
Problem, Solution, SitRep, or ?: 
Problem
Situation Report

UK to allow emergency use of any effective COVID-19 vaccine

Fri, 2020-08-28 10:10 — mike kraft
UK to allow emergency use of any effective COVID-19 vaccine LONDON (AP) — Britain is preparing to revise its laws to allow the emergency use of any effective coronavirus vaccine before it is fully licensed — but only if the shots meet required safety and... AP NEWS

LONDON (AP) — Britain is preparing to revise its laws to allow the emergency use of any effective coronavirus vaccine before it is fully licensed — but only if the shots meet required safety and quality standards.

Country / Region Tags: 
Europe
UK - London
United Kingdom
General Topic Tags: 
COVID-19
Contagion
Disease
Government
Health
Pandemics
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report

New reckoning for WHO vaccine plan as governments go it alone

Fri, 2020-08-28 09:46 — mike kraft

GENEVA (Reuters) - Wealthier countries that join the World Health Organization’s COVID-19 vaccine plan are being offered a new option to pick and choose which shots they get while reserving a right to receive their “full share” of doses, documents seen by Reuters show.

Country / Region Tags: 
Australia
Canada
China
Europe
France
Germany
Global
Japan
UK - London
Middle East
South Korea
SouthEast Asia
United Kingdom
United Nations
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Government
Health
Pandemics
Research
Science
Problem, Solution, SitRep, or ?: 
Problem
Situation Report

Moderna and Pfizer’s COVID-19 vaccine candidates require ultra-low temperatures, raising questions about storage, distribution

Thu, 2020-08-27 19:34 — mike kraft
Moderna and Pfizer’s COVID-19 vaccine candidates require ultra-low temperatures, raising questions about storage, distribution The COVID-19 vaccine candidates being developed by Moderna Inc. and BioNTech and Pfizer Inc. will require stringent standards for refrigeration, and that may... Jaimy Lee MarketWatch
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Health
Research
Science
Problem, Solution, SitRep, or ?: 
Problem
Situation Report

EU pays 336 million euros for doses of AstraZeneca's potential COVID-19 vaccine

Thu, 2020-08-27 11:20 — mike kraft
EU pays 336 million euros for doses of AstraZeneca's potential COVID-19 vaccine The European Commission has paid 336 million euros ($396 million) to secure at least 300 million doses of the potential COVID-1 vaccine being developed by British drug maker AstraZeneca , a spokesman said on Thursday. Reuters Editorial U.S.
Country / Region Tags: 
Europe
General Topic Tags: 
COVID-19
Health
Pandemics
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report

Elizabeth Warren, other lawmakers seek details of Warp Speed co-chief Moncef Slaoui’s contract

Wed, 2020-08-26 14:32 — mike kraft
Elizabeth Warren, others seek details of Warp Speed co-chief Moncef Slaoui’s contract Christopher Rowland Washington Post
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Government
Health
Pandemics
Policy
Politics
Research
Problem, Solution, SitRep, or ?: 
Problem
Situation Report

Moderna says its coronavirus vaccine shows promising results in small trial of elderly patients

Wed, 2020-08-26 14:00 — mike kraft
Moderna says its coronavirus vaccine shows promising results in small trial of elderly patients The vaccine produced neutralizing antibodies, which researchers believe are necessary to build immunity to the virus, and killer T-cells, Moderna said. Berkeley Lovelace Jr. CNBC
Country / Region Tags: 
Global
United Kingdom
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Flu Season Could Make Coronavirus Testing Delays Even Worse

Wed, 2020-08-26 10:20 — mike kraft

Come fall, the rise of influenza and other seasonal respiratory infections could exacerbate already staggering delays in coronavirus testing, making it easier for the virus to spread unnoticed, experts said.

In typical years, doctors often don’t test for flu, simply assuming that patients with coughs, fevers and fatigue during the winter months are probably carrying the highly infectious virus. But this year, with the coronavirus bringing similar symptoms, doctors will need to test for both viruses to diagnose their patients — further straining supply shortages in an already overwhelmed testing system.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Health
Pandemics
Research
Science
Problem, Solution, SitRep, or ?: 
Problem

Pages

howdy folks
Page loaded in 0.830 seconds.